Friday, 11 September 2026

Indian corporate news, decoded into deal flow

NSE LIVE
NIFTY 50 INDIA VIX
as of
MARKETS
DEAL FLOW
Vikram Solar Secures 124 MW Module… ▲ Order Book Can Fin Homes Unveils ₹297 Crore… ▲ Capex & Future Plan AXISCADES Completes ₹234 Crore Cloud Wave… ▲ Mergers & Acquisitions NSE IPO 2026: ₹26,580 Crore Offer,… ▲ IPOs Fabtech Technologies’ UAE Subsidiary Completes 14,000… ▲ Capex & Future Plan Indo Tech Transformers Sets Up Next… ▲ Capex & Future Plan JSW Infrastructure Completes ₹467 Crore Acquisition… ▲ Mergers & Acquisitions
Home / Capex & Future Plans / Fabtech Technologies’ UAE Subsidiary Completes 14,000 Sq. M Facility for Himalaya Wellness in Under a Year
CX · Capex & Future Plans

Fabtech Technologies’ UAE Subsidiary Completes 14,000 Sq. M Facility for Himalaya Wellness in Under a Year

Fabtech Technologies’ UAE Subsidiary Completes 14,000 Sq. M Facility for Himalaya Wellness in Under a Year

Fabtech Technologies Limited (NSE: FABTECH, BSE: 544558) has announced an international execution milestone, with its step-down subsidiary FTS Cleanrooms Systems LLC, UAE, completing a 14,000 sq. metre turnkey facility for Himalaya Wellness Company in Dubai in less than one year.

The facility has been developed to support pharmaceutical and cosmetic manufacturing operations with different cleanroom requirements, strengthening Fabtech’s presence in the Middle East healthcare and life-sciences engineering market.

14,000 Sq. M Facility Delivered in Less Than a Year

FTS Cleanrooms Systems LLC handled the project through an integrated delivery model covering design, installation and validation under a single structure.

According to the company, retaining the same project team throughout the project helped maintain continuity across the different execution stages and reduce coordination requirements among multiple contractors.

The project was completed within the planned timeframe of less than one year.

The facility forms part of Himalaya Wellness’ manufacturing operations in Dubai and provides cleanroom infrastructure for the production of pharmaceutical and cosmetic products.

Strengthening Fabtech’s UAE and International Presence

The project is significant from a strategic perspective as it adds to Fabtech’s portfolio of international healthcare and pharmaceutical engineering projects.

FTS Cleanrooms Systems LLC is based in the UAE and provides end-to-end engineering solutions to the healthcare sector across the MENA region.

Fabtech said the successful completion of the project supports its broader international expansion strategy, particularly in the Middle East and other pharmaceutical and healthcare markets.

Management Sees Larger International Opportunity

Aman Anavkar, Chief Growth Officer, Fabtech Technologies Limited, said the successful completion of the 14,000 sq. metre facility in under a year validates the company’s engineering capabilities, project execution discipline and regional teams.

He added that the project demonstrates Fabtech’s ability to provide integrated, end-to-end engineering solutions for sophisticated pharmaceutical, biotechnology and healthcare manufacturing facilities.

According to management, the execution for a globally recognised healthcare brand increases confidence in taking on larger and more sophisticated international projects.

The company plans to continue building capabilities in cleanroom infrastructure, pharmaceutical engineering and turnkey project execution, while expanding its presence across high-growth international healthcare and life-sciences markets.

Fabtech Has Executed 750+ Projects Across 62 Countries

Fabtech Technologies operates across several segments of pharmaceutical engineering, including:

  • Cleanroom infrastructure and partitions
  • HVAC systems
  • Pharmaceutical MEP
  • Process piping
  • Clean utilities
  • Purified water and water-for-injection systems
  • Containment solutions
  • Pharmaceutical equipment manufacturing
  • Turnkey project management
  • Technology transfer

The company said it has executed 750+ projects across 62 countries, supported by a workforce of more than 650 professionals.

Its regional operations include markets such as the UAE, Saudi Arabia, Egypt, Nigeria, the UK, Algeria and Sri Lanka.

What This Means for Investors

The latest development is primarily an execution and international expansion milestone, rather than a disclosed new order announcement.

The company has not disclosed the monetary value of the Himalaya Wellness project in this release, so its direct impact on revenue or order book cannot be quantified from the announcement.

However, successful execution of a large specialised pharmaceutical facility in the UAE could strengthen Fabtech’s credentials for securing additional projects in the Middle East and other international healthcare markets.

Investors will therefore be watching for further disclosures on new orders, project values, international order inflows and the contribution of overseas operations to revenue and profitability.

Key Takeaways

14,000 sq. m – size of the completed facility

Less than one year – project execution period

UAE – location of the facility

Himalaya Wellness – customer

Pharma & cosmetics – manufacturing applications supported

750+ projects – projects executed by Fabtech across 62 countries

650+ professionals – global workforce

Outlook

Fabtech Technologies is using its engineering and cleanroom capabilities to expand its international healthcare and pharmaceutical footprint. The completion of the Himalaya Wellness facility adds another reference project to its UAE portfolio and highlights its ability to execute specialised turnkey projects.

For investors, the more important catalyst going forward will be whether this execution capability translates into larger international orders, stronger order visibility and higher revenue from the MENA and global pharmaceutical markets.

Disclaimer: This article is based on the company’s exchange filing and press release dated September 11, 2026. The project value and its financial impact were not disclosed in the announcement. This article is for informational purposes only and should not be considered investment advice. Investments in securities are subject to market risks.